- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/00 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patent holdings for IPC class C07D 235/00
Total number of patents in this class: 125
10-year publication summary
|
8
|
4
|
6
|
6
|
11
|
13
|
1
|
7
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4493 |
6 |
| Merck Sharp & Dohme Corp. | 2183 |
5 |
| The Regents of the University of Michigan | 4985 |
5 |
| Orsobio, Inc. | 18 |
4 |
| Medshine Discovery Inc. | 587 |
3 |
| Merck Patent GmbH | 5728 |
2 |
| Board of Regents, The University of Texas System | 6107 |
2 |
| The Board of Trustees of the University of Illinois | 2751 |
2 |
| The Broad Institute, Inc. | 1977 |
2 |
| Children's Medical Center Corporation | 1959 |
2 |
| Regents of the University of Minnesota | 2789 |
2 |
| Sumitomo Bakelite Co., Ltd. | 1534 |
2 |
| University of Maryland, Baltimore | 1068 |
2 |
| The University of Montana | 103 |
2 |
| Kyowa Kirin Co., Ltd. | 363 |
2 |
| Aryl Therapeutics, Inc. | 2 |
2 |
| Genesee Valley Innovations, LLC | 2187 |
2 |
| Glaxo Group Limited | 4375 |
1 |
| Novartis AG | 10262 |
1 |
| BASF SE | 21303 |
1 |
| Other owners | 75 |